Press release
mRNA Synthesis and Manufacturing Market to Increase at a Steady Growth Rate of ~4% by 2034 | DelveInsight
mRNA Synthesis and Manufacturing Market
Messenger RNA (mRNA) has emerged as a transformative tool in modern medicine, powering breakthrough vaccines and advancing the future of gene-based therapies. The success of mRNA-based COVID-19 vaccines showcased the potential of this technology and accelerated global investment into mRNA research, synthesis, and scalable manufacturing.
Beyond infectious diseases, mRNA therapies are being actively explored for oncology, rare genetic disorders, autoimmune diseases, and personalized medicine. As a result, the global mRNA synthesis and manufacturing market is positioned for strong growth, driven by the convergence of biotechnology, advanced manufacturing systems, and increasing healthcare demand worldwide.
In 2024, the global mRNA synthesis and manufacturing market is estimated at USD 15.6 billion and is expected to reach USD 64.2 billion by 2034, expanding at a CAGR of 15.1%.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/72684
Market Overview
• Market Size 2024: USD 15.6 billion
• Forecast 2034: USD 64.2 billion
• CAGR (2025-2034): 15.1%
Key Drivers
• Rapid expansion of mRNA-based vaccines and therapies.
• Rising demand for oncology-focused mRNA therapeutics.
• Advances in lipid nanoparticle (LNP) delivery technologies.
• Growing partnerships between biotech firms, CDMOs, and pharma giants.
• Increased government funding and global preparedness for future pandemics.
Key Challenges
• Complex and costly large-scale manufacturing processes.
• Cold chain storage and distribution challenges for mRNA-based products.
• Regulatory hurdles and quality assurance requirements.
• High competition from alternative modalities (DNA vaccines, viral vectors, protein therapies).
Leading Players
Moderna, BioNTech, CureVac, Pfizer, Thermo Fisher Scientific, Merck KGaA, Lonza, Catalent, Ginkgo Bioworks, and Aldevron.
Segmentation Analysis
By Product Type
• mRNA Synthesis Kits & Reagents
• Plasmid DNA Templates
• Enzymes & Nucleotides
• Lipid Nanoparticles (LNPs) & Delivery Systems
• Custom mRNA Constructs
By Application
• Vaccines (infectious diseases, cancer vaccines)
• Therapeutics (oncology, rare diseases, autoimmune disorders)
• Research & Development (academic and biotech labs)
• Personalized Medicine
By End User
• Pharmaceutical & Biotechnology Companies
• Contract Development and Manufacturing Organizations (CDMOs)
• Research Institutes & Academic Centers
• Diagnostic Laboratories
By Manufacturing Scale
• Clinical-Scale Manufacturing
• Commercial-Scale Manufacturing
Summary:
Vaccines remain the largest application, but therapeutic mRNA applications-particularly oncology-are emerging as high-growth segments. CDMOs are critical end users, helping pharmaceutical companies scale production while reducing infrastructure costs.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/72684/mrna-synthesis-and-manufacturing-market
Regional Analysis
• North America
The largest market, led by the U.S., where Moderna, Pfizer-BioNTech, and key CDMOs dominate. Strong government funding, established biotech infrastructure, and high R&D spending drive growth.
• Europe
Major players such as BioNTech and CureVac anchor the region. The EU supports growth through funding initiatives and partnerships for pandemic preparedness and cancer therapies.
• Asia-Pacific
Expected to record the fastest CAGR. China, Japan, South Korea, and India are investing heavily in domestic mRNA production, supported by government-backed innovation programs and collaborations with Western firms.
• Middle East & Africa
Gradually expanding, with investments in vaccine manufacturing infrastructure and local partnerships to reduce dependency on imports.
• Latin America
Brazil and Mexico lead regional demand, supported by healthcare modernization and technology transfer partnerships for vaccine manufacturing.
Summary:
North America and Europe remain leaders due to strong biotech ecosystems, while Asia-Pacific is emerging as the most dynamic growth region, fueled by government investment and domestic innovation.
Market Dynamics
Growth Drivers
1. Expanding use of mRNA beyond vaccines, particularly in oncology and rare diseases.
2. Increasing reliance on CDMOs for scalable, cost-effective production.
3. Technological improvements in synthesis, purification, and delivery.
4. Strategic collaborations between pharma, biotech startups, and academic institutions.
5. Strong funding support from public health agencies and governments.
Challenges
• High cost of raw materials and complex supply chains.
• Cold chain logistics limiting accessibility in low-income regions.
• Regulatory uncertainty around long-term safety for newer applications.
• Need for standardization in large-scale production.
Latest Trends
• Development of self-amplifying mRNA (saRNA) to reduce doses and improve efficacy.
• Growing adoption of personalized cancer vaccines using patient-specific tumor antigens.
• Expansion of AI and automation in synthesis processes for speed and accuracy.
• Increasing establishment of regional manufacturing hubs to strengthen supply chains.
• Rapid rise of partnerships between biotech firms and CDMOs to expand global capacity.
Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72684
Competitor Analysis
Key Players
• Moderna
• BioNTech
• CureVac
• Pfizer
• Thermo Fisher Scientific
• Merck KGaA
• Lonza
• Catalent
• Ginkgo Bioworks
• Aldevron
Competitive Landscape
The market is highly competitive and innovation-driven, with Moderna and BioNTech at the forefront of commercial mRNA applications. CDMOs such as Lonza, Catalent, and Thermo Fisher play a pivotal role in scaling production for biotech firms. Meanwhile, CureVac and Ginkgo Bioworks are pushing the boundaries of RNA design and delivery technologies. Collaborations, licensing agreements, and government-backed projects are common strategies shaping the competitive landscape.
Conclusion
The mRNA synthesis and manufacturing market has shifted from niche research to a cornerstone of modern biopharmaceutical innovation. With a 2024 value of USD 15.6 billion, it is projected to reach USD 64.2 billion by 2034, expanding at a CAGR of 15.1%.
Future opportunities will focus on oncology therapeutics, personalized medicine, and pandemic preparedness. Companies investing in technological innovation, global partnerships, and regional manufacturing capacity will be best positioned to succeed in this fast-evolving market.
This report is also available in the following languages : Japanese (mRNA合成および製造市場), Korean (mRNA 합성 및 제조 시장), Chinese (mRNA合成与制造市场), French (Marché de la synthèse et de la fabrication d'ARNm), German (Markt für mRNA-Synthese und -Herstellung), and Italian (Mercato della sintesi e della produzione di mRNA), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/72684
Our More Reports:
Blood Brain Barrier
https://exactitudeconsultancy.com/reports/72918/blood-brain-barrier-market
Continuous Manufacturing
https://exactitudeconsultancy.com/reports/72920/continuous-manufacturing-market
Peptide Synthesis
https://exactitudeconsultancy.com/reports/72922/peptide-synthesis-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release mRNA Synthesis and Manufacturing Market to Increase at a Steady Growth Rate of ~4% by 2034 | DelveInsight here
News-ID: 4204191 • Views: …
More Releases from Exactitude Consultancy
Amnesia Market to Reach USD 8.9 Billion by 2034, Expanding Growing at 6.6% CAGR
Introduction
Amnesia, characterized by partial or complete memory loss, can result from brain injury, stroke, dementia, psychological trauma, substance abuse, or neurodegenerative diseases such as Alzheimer's. While traditionally associated with aging, amnesia is increasingly recognized across all age groups due to traumatic brain injuries, mental health disorders, and substance-related complications.
Growing awareness of neurological health, advances in neuroimaging, and the rise of cognitive rehabilitation therapies are driving innovation in this space. Pharmaceutical…
Pediatric Brain Tumours Market is expected to reach USD 4.8 billion by 2034, wit …
Brain tumours are among the most common solid tumours in children and represent a significant cause of cancer-related mortality in pediatric populations. Conditions such as medulloblastoma, gliomas, ependymomas, and astrocytomas account for the majority of cases. Treatment strategies include surgery, chemotherapy, radiotherapy, and increasingly, targeted therapies and immunotherapies designed to minimize long-term side effects.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72687
Advancements in genomic profiling, molecular diagnostics, and precision…
Pharma Contract Research Organization (CRO) Services Market to Reach USD 193.7 B …
Introduction
The pharmaceutical industry is undergoing a rapid transformation as companies seek to accelerate drug development, reduce costs, and navigate increasingly complex regulatory landscapes. Contract Research Organizations (CROs) have become essential partners, offering specialized expertise in clinical trials, preclinical research, regulatory consulting, and data management.
With rising demand for innovative therapies, biologics, biosimilars, and personalized medicine, outsourcing to CROs is becoming a strategic necessity. These organizations not only provide cost-effective solutions but…
Neuroendocrine Breast Tumor Market to Reach USD 1.53 Billion by 2034, Growing at …
Introduction
Neuroendocrine breast tumors (NETs) are a rare and heterogeneous group of breast cancers characterized by neuroendocrine differentiation. Although they account for a small percentage of all breast cancers, their clinical significance is increasing due to improved diagnostic awareness and evolving treatment approaches.
Historically, limited research and lack of standardized diagnostic criteria slowed therapeutic progress. However, recent advances in imaging technologies, molecular profiling, and oncology research are improving detection rates and shaping…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
